RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+5.69%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.2B
AUM Growth
+$2.2B
(+1.6%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
26.51%
Holding
158
New
11
Increased
47
Reduced
20
Closed
14
Top Buys
| 1 |
Teleflex
TFX
|
$22.8M |
| 2 |
Stryker
SYK
|
$19.6M |
| 3 |
Hologic
HOLX
|
$14.3M |
| 4 |
Zimmer Biomet
ZBH
|
$11.8M |
| 5 |
Molina Healthcare
MOH
|
$11.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$28.9M |
| 2 |
Danaher
DHR
|
$19.3M |
| 3 |
Medtronic
MDT
|
$19.2M |
| 4 |
BCR
CR Bard Inc.
BCR
|
$18.4M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.8M |
Sector Composition
| 1 | Healthcare | 85.2% |
| 2 | Financials | 2.8% |
| 3 | Consumer Discretionary | 0.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WMGI
51
DELISTED
Wright Medical Group Inc
WMGI
| $15.5M | 0.71% |
700,000
+30,000
| +4% | +$666K |
|
52
FibroGen
FGEN
$48.4M
| $15.4M | 0.7% |
325,000
| – | – |
|
53
Ardelyx
ARDX
$1.57B
| $15M | 0.68% |
2,275,557
+275,557
| +14% | +$1.82M |
|
54
Baxter International
BAX
$12.1B
| $14.9M | 0.67% |
230,000
| – | – |
|
55
Align Technology
ALGN
$9.59B
| $14.8M | 0.67% |
66,750
+5,450
| +9% | +$1.21M |
|
|
56
Zimmer Biomet
ZBH
$20.8B
| $14.4M | 0.65% |
119,000
+97,900
| +464% | +$11.8M |
|
57
Sarepta Therapeutics
SRPT
$1.98B
| $14.4M | 0.65% |
258,000
-1,200
| -0.5% | -$66.8K |
|
58
AnaptysBio
ANAB
$630M
| $14.3M | 0.65% |
142,400
-7,600
| -5% | -$765K |
|
|
59
Hologic
HOLX
$14.7B
| $14.3M | 0.65% |
+335,000
| New | +$14.3M |
|
60
Axogen
AXGN
$718M
| $13.5M | 0.61% |
477,500
+77,500
| +19% | +$2.19M |
|
61
Amicus Therapeutics
FOLD
$2.42B
| $13.1M | 0.59% |
910,000
| – | – |
|
62
Encompass Health
EHC
$12.5B
| $13.1M | 0.59% |
265,000
| – | – |
|
|
ALDR
63
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $12.1M | 0.55% |
1,055,000
+180,000
| +21% | +$2.06M |
|
|
NVTA
64
DELISTED
Invitae Corporation
NVTA
| $11.9M | 0.54% |
1,306,000
| – | – |
|
|
DERM
65
DELISTED
Dermira, Inc.
DERM
| $11.7M | 0.53% |
420,000
+20,000
| +5% | +$556K |
|
66
Prothena Corp
PRTA
$452M
| $11.6M | 0.53% |
310,000
+500
| +0.2% | +$18.7K |
|
67
Ascendis Pharma
ASND
$12.1B
| $11.2M | 0.51% |
280,000
| – | – |
|
|
XENT
68
DELISTED
Intersect ENT, Inc
XENT
| $11.2M | 0.51% |
345,000
| – | – |
|
69
BioMarin Pharmaceuticals
BMRN
$11.3B
| $11.1M | 0.51% |
125,000
| – | – |
|
|
AIMT
70
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $11.1M | 0.5% |
293,000
| – | – |
|
|
BPMC
71
DELISTED
Blueprint Medicines
BPMC
| $11M | 0.5% |
146,500
+60,000
| +69% | +$4.52M |
|
|
JUNO
72
DELISTED
Juno Therapeutics, Inc.
JUNO
| $10.5M | 0.48% |
230,000
+5,000
| +2% | +$229K |
|
|
ODT
73
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $10.3M | 0.47% |
+410,000
| New | +$10.3M |
|
74
Aclaris Therapeutics
ACRS
$223M
| $10.2M | 0.46% |
415,000
-25,000
| -6% | -$617K |
|
75
Rigel Pharmaceuticals
RIGL
$710M
| $9.6M | 0.44% |
2,475,000
+1,475,000
| +148% | +$5.72M |
|